(Q84349790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Management of neuronopathic Gaucher disease: revised recommendations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

A Vellodi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

E H Davies

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

B Bembi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

T Collin-Histed

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

E Mengel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

A Erikson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

R Schiffmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

5 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

660-664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19655269%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-009-1164-2

4 February 2020

exact match

0 references

cites work

Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases.

1 reference

12 December 2020

Characterization of neuronopathic Gaucher disease among ethnic Poles

1 reference

12 December 2020

Pathological findings in Gaucher disease type 2 patients following enzyme therapy

1 reference

12 December 2020

Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease

1 reference

12 December 2020

Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease

1 reference

12 December 2020

A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules

1 reference

12 December 2020

Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease

1 reference

12 December 2020

Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.

1 reference

12 December 2020

Enzyme replacement therapy in type III Gaucher disease

1 reference

12 December 2020

A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease

1 reference

12 December 2020

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype

1 reference

12 December 2020

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.

1 reference

12 December 2020

Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease

1 reference

12 December 2020

Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy.

1 reference

12 December 2020

Enzyme replacement therapy of infantile Gaucher disease

1 reference

12 December 2020

Ocular motor abnormalities in Gaucher disease

1 reference

12 December 2020

Management of neuronopathic Gaucher disease: a European consensus.

1 reference

12 December 2020

Splenectomy in Gaucher disease: new management dilemmas

1 reference

12 December 2020

New Gaucher disease mutations in exon 10: a novel L444R mutation produces a new NciI site the same as L444P

1 reference

12 December 2020

Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.

1 reference

12 December 2020

Therapeutic goals in the treatment of Gaucher disease.

1 reference

12 December 2020

Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.

1 reference

12 December 2020

Gaucher disease: enzyme therapy in the acute neuronopathic variant

1 reference

12 December 2020

Communicating hydrocephalus in a patient with Gaucher's disease type 3

1 reference

12 December 2020